Similar articles

• Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint.

  Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS. Boultwood J, et al. Genomics. 1994 Feb;19(3):425-32. doi: 10.1006/geno.1994.1090. Genomics. 1994. PMID: 8188284
• [Refractory anemia: the entity and recent findings].

  Shimamoto T, Ohyashiki K. Shimamoto T, et al. Ryoikibetsu Shokogun Shirizu. 1998;(22 Pt 3):183-6. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9851116 Review. Japanese. No abstract available.
• Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.

  Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, Jädersten M, Killick S, Vyas P, Hellström-Lindberg E, Wainscoat JS, Boultwood J. Pellagatti A, et al. Br J Haematol. 2011 Oct;155(2):272-4. doi: 10.1111/j.1365-2141.2011.08672.x. Epub 2011 Apr 15. Br J Haematol. 2011. PMID: 21492127 No abstract available.
• 5q- and disordered haematopoiesis.

  Bunn HF. Bunn HF. Clin Haematol. 1986 Nov;15(4):1023-35. Clin Haematol. 1986. PMID: 3552346 Review. No abstract available.
• [5q anomaly in myelodysplasia and acute myelocytic leukemia].

  Robak T. Robak T. Acta Haematol Pol. 1990 Jul-Dec;21(2):235-42. Acta Haematol Pol. 1990. PMID: 2151871 Review. Polish. No abstract available.